PEOPLE - Adherex Technologies makes promotion:
This article was originally published in Clinica
Canadian biotechnology company Adherex Technologies (Ottawa) has promoted Robin Norris to the position of president. Dr Norris, who joined the company in January 2002, will maintain his responsibilities as COO.
You may also be interested in...
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.